Phreesia, Inc. (PHR)
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$10.94-1.44%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · PHR
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -27.4% |
| Our one-year growth estimate | diamond | 3.9% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 31.3 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name has erratic recent earnings surprises and is on a run of consecutive earnings misses. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 21 industry peers · Company calendar date is not available
PHR — earnings miss
Dated 2026-09-02
Results of Operations and Financial Condition On September 2, 2026, Phreesia, Inc. (the “Company”) announced its financial results for the fiscal second quarter ended July 31, 2026 by issuing a stakeholder letter (the "Letter") and a press release. Copies of the press release and the Letter are furnished as Exhibits 99.1 and 99.2, respectively, to this Current Report on Form 8-K and are incorporated by reference herein. The information furnished under this
Why it matters: Meeting or exceeding this target shows progress toward the $510M-$520M goal for FY 2027.
Supportive ifQ2 revenue reported at or above $130M.
Worry ifQ2 revenue reported below $130M.
Why it matters: The restructuring plan aims to cut operating costs. Success can lead to more profits.
Supportive ifOperating costs drop a lot due to the restructuring.
Worry ifOperating costs stay the same or go up.
Why it matters: A successful restructuring could lower Phreesia's costs and raise profits.
Supportive ifPhreesia sees a big drop in operating expenses from the restructuring plan.
Worry ifOperating expenses do not change or rise, even with the restructuring plan.
Why it matters: If revenue growth picks up, it could indicate a positive shift for Phreesia's market.
Supportive if3-year revenue growth in the health care sector rises above 12 percent.
Worry if3-year revenue growth in the health care sector stays below 10 percent.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$199 on $10,000 · ±2.0% | How much price usually moves either way. |
| Bad day | $523 loss on $10,000 · 5.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $7,135 loss on $10,000 · 71.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: The results will show Phreesia's financial health and growth path.
Watch forPhreesia reports revenue growth and positive net income in the earnings results.
Also watch forPhreesia reports revenue decline or net loss in the earnings results.
Why it matters: Confirming the revenue target of $510M-$520M shows strong growth momentum. It reassures investors about the company's future.
Supportive ifManagement confirms revenue growth in the next earnings call on September 3, 2026.
Worry ifManagement lowers the revenue guidance below $510M for FY 2027.
Why it matters: The adjusted EBITDA target of $125M-$135M is crucial for growth. Meeting this target signals strong operational performance.
Supportive ifAdjusted EBITDA for Q2 exceeds $135M.
Worry ifAdjusted EBITDA for Q2 falls below $125M.
Why it matters: The adjusted EBITDA target is $125M-$135M. Meeting this target shows good cost management.
Supportive ifAdjusted EBITDA for fiscal 2027 falls within the $125M-$135M range.
Worry ifAdjusted EBITDA for fiscal 2027 is below $125M. This suggests financial strain.
Why it matters: Revenue guidance of $510M-$520M is crucial for Phreesia's growth outlook. A miss could signal deeper issues.
Worry ifFiscal 2027 revenue is confirmed to be between $510M and $520M.
Less concerning ifRevenue guidance lowered again from the $510M-$520M range.
Why it matters: AccessOne is expected to contribute about $37 million to revenue. Its performance is key for growth.
Supportive ifAccessOne revenue meets or is above the $37 million target.
Worry ifAccessOne revenue is much lower than the $37 million target.
Why it matters: The restructuring plan aims to reduce costs. Successful execution is vital for improving margins.
Supportive ifThe restructuring plan is done, and expected savings are achieved.
Worry ifThe restructuring plan is delayed or costs are higher than expected.